Abstract
The aim of this study was to evaluate the possible protective effects of quercetin (QE) against cholestatic oxidative stress and liver damage in the common bile duct ligated rats. A total of 24 male Wistar albino rats were divided into three groups: control, bile duct ligation (BDL) and BDL + received QE; each group contain 8 animals. The rats in QE treated groups were given QE (15 mg/kg) once a day intraperitoneally for 4 weeks starting 3 days prior to BDL operation. The changes demonstrating the bile duct proliferation and fibrosis in expanded portal tracts include the extension of proliferated bile ducts into lobules, mononuclear cells, and neutrophil infiltration into the widened portal areas were observed in BDL group. Treatment of BDL with QE attenuated alterations in liver histology. The alpha smooth muscle actin (α-SMA), transforming growth factor beta (TGF-β1) positive cells and the activity of TUNEL in the BDL were observed to be reduced with the QE treatment. The data indicate that QE attenuates BDL-induced cholestatic liver injury, bile duct proliferation, and fibrosis. The hepatoprotective effect of QE is associated with antioxidative potential.
Similar content being viewed by others
References
Afanas’ev IB, Dorozhko I, Brodskii AV, Korstyuk VA, Potapovitch A (1989) Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem Pharmacol 38:1763–1769
Akiyoshi H, Terada T (1998) Mast cell, myofibroblast and nerve terminal complexes in carbon tetrachloride-induced cirrhotic rat livers. J Hepatol 29:112–119
Aksu B, Umit H, Kanter M, Guzel A, Inan M, Civelek S, Aktas C, Uzun H (2009) Effects of sphingosylphosphorylcholine against cholestatic oxidative stress and liver damage in the common bile duct ligated rats. J Pediatr Surg 44:702–710
Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115:209–218
Benedetti A, Alvaro D, Bassotti C, Gigliozzi A, Ferretti G, La Rosa T et al (1997) Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver. Hepatology 26:9–21
Bolt MJ, Sitrin MD, Favus MJ et al (1981) Hepatic vitamin D 25- hydroxylase: inhibition by bile duct ligation or bile salts. Hepatology 1:436–440
Bors W, Heller W, Michel C, Saran M (1990) Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods Enzymol 186:343–355
Braun L, Mead JE, Panzica M, Mikumo R, Bell GI, Fausto N (1988) Transforming growth factor, mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc NatI Acad Sci USA 85:1539–1543
Braun L, Gruppuso P, Mikumo R, Fausto N (1990) Transforming growth factor beta 1 in liver carcinogenesis: messenger RNA expression and growth effects. Cell Growth Differ 1(3):103–111
Coffey RJ, Kost LJ, Lyons RM, Moses HL, La-Russo NF (1987) Hepatic processing of transforming growth factor- β in the rat. J Clin Invest 80:750–757
Corsini A, Mazzotti M, Raiteri M, Soma MR, Gabbiani G, Fumagalli R, Paoletti R (1993) Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase. Atherosclerosis 101:117–125
Deschner EE, Ruperto J, Wong G, Newmark HL (1991) Quercetin and rutin as inhibitors of azoxymehanol-induced coloni neoplasia. Carcinogenesis 12:1193–1196
Friedman SL (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275:2247–2250
Gaedeke J, Nooble AN, Border AW (2004) Curcumin blocks multiple sites of the TGF-b signaling cascade in renal cells. Kidney Int 66:112–120
Gressner AM, Weiskirchen R (2006) Modern pathogenic concepts of liver fibrosis suggest stellate cells and TGF-b as major players and therapeutic targes. J Cell Mol Med 10:76–99
Hsu SM, Raine L, Fanger H (1981) Use of avidinbiotin-peroxidase complex (ABC) in immunperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577–580
Inal ME, Akgun A, Kahraman A (2002) Radioprotective effects of exogenous glutathione against whole-body gamma-ray irradiation: age- and gender-related changes in malondialdehyde levels, superoxide dismutase and catalase activities in rat liver. Methods Find Exp Clin Pharmacol 24:209–212
Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696–699
Kanter M, Yener Z (2001) A rabbit model for liver fibrosis. Scand J Lab Anim Sci 28(4):213–223
Karaman A, Iraz M, Kirimlioglu H et al (2006) Hepatic damage in biliaryobstructed rats is ameliorated by leflunomide treatment. Pediatr Surg Int 22:701–708
Kountouras J, Billing BH, Scheuer PJ (1984) Prolonged bileduct obstruction: a new experimental model for cirrhosis inthe rat. Br J Exp Pathol 65:305–311
Kullak-Ublick GA, Meier PJ (2000) Mechanisms of cholestasis. Clin Liver Dis 4:357–385
Lama HB, Yehb CH, Chengc KC, Hsud CT, Chengc JT (2008) Effect of cholinergic denervation on hepatic fibrosis induced by carbon tetrachloride in rats. Neurosci Lett 438:90–95
Laughton MJ, Evans PJ, Moroney MA, Hoult JR, Halliwell B (1991) Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability. Biochem Pharmacol 42:1673–1681
Liu TZ, Lee KT, Chern CL et al (2001) Free radical triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor kappab. Ann Clin Lab Sci 31:383–390
Maher JJ, McGuire RF (1990) Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest 86:1641–1648
Marley R, Holt S, Fernando B (1999) Lipoic acid prevents development of the hyperdynamic circulation in anesthetized rats with biliary cirrhosis. Hepatology 29:1358–1363
Matsuoka M, Tsukamoto H (1990) Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor-β implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology 11:599–605
Middleton E (1998) Effect of plant flavonoids on immune and inflammatory cell function. Adv Exp Med Biol 439:175–182
Miyazaki H, van Eyken P, Roskams T et al (1993) Transient expression of tenascin in experimentally induced cholestatic fibrosis in rat liver: an immunohistochemical study. J Hepatol 19:353–366
Morris J, Gollo G, Scheuer P et al (1975) Percutaneous liver biopsy in patients with large bile duct obstruction. Gastroenterology 68:750–754
Nagy P, Evarts RP, McMahon JB, Thorgeirsson SS (1989) Role of TGF-beta in normal differentiation and oncogenesis in rat liver. Mol Carcinog 2:345–354
Nahdi A, Hammami I, Kouidhi W, Chargui A, Ben Ammar A, Hamdaoui M, El May A, May El (2010) Protective effects of crude garlic by reducing iron-mediated oxidative stress, proliferation and autophagy in rats. J Mol Hist 41:233–245
Nan JX, Park EJ, Kim HJ et al (2000) Antifibrotic effects of the methanol extract of Polygonum aviculare in fibritic rats induced by bile duct ligation and scission. Biol Pharm Bull 23:240–243
Ogata Y, Takahashi M, Takeuchi K, Ueno S, Mano H, Ookawara S et al (2002) Fluvastatin induces apoptosis in rat neonatal cardiac myocytes: a possible mechanism of statin-attenuated cardiac hypertrophy. J Cardiovasc Pharmacol 40:907–915
Parola M, Leonarduzzi G, Robino G, Albano E, Poli G (1996) On the role of lipid peroxidation in the pathogenesis of liver damage induced by long-standing cholestasis. Free Radic Biol Med 20:351–359
Roberts AB, Sporn MB (1990) The transforming growth factor-β’s. In: Sporn MB, Roberts AB (eds) Handbook of experimental pharmacology. Peptide growth factors and their receptors, vol 95, part 1. Springer, Heidelberg, FRG, pp 419–472
Roggin KK, Kim JC, Kurkchubasche AG, Papa EF, Vezeridis AM, Tracy TF (2001) Macrophage phenotype during cholestatic injury and repair: the persistent inflammatory response. J Pediatr Surg 36:220–228
Schmitt-Graff A, Kruger S, Bochard F, Gabbiani G, Denk H (1991) Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol 138:1233–1242
Serviddio G, Pereda J, Pallardo FV, Carretero J, Borras C, Cutrin J et al (2004) Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress. Hepatology 39:711–720
Strazzabosco M, Fabris L, Spirli C (2005) Pathophysiology of cholangiopathies. J Clin Gastroenterol 39:90–102
Tieppo J, Cuevas MJ, Vercelino R, Tunon MJ, Marroni NP, Gonzalez-Gallego J (2009) Quercetin administration ameliorates pulmonary complications of cirrhosis in rats. J Nutr 139:1339–1346
Tracy TF Jr, Fox E (1996) Molecular and cellular control points in pediatric liver injury and repair. Semin Pediatr Surg 5:175–181
Vessal M, Hemmati M, Vasie M (2003) Antidiabetic effects of quercetinin streptozocin-induced diabetic rats. Comp Biochem Physiol C Toxicol Pharmacol 135:357–364
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kanter, M. Protective effect of quercetin on liver damage induced by biliary obstruction in rats. J Mol Hist 41, 395–402 (2010). https://doi.org/10.1007/s10735-010-9301-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10735-010-9301-7